Scientists at the University of California, San Diego School of Medicine have elucidated a genetic interaction that may prove key to the development and progression of glaucoma, a blinding…
Uncategorized
Surgeon: Better to rescue subluxated IOLs than to replace them
BARCELONA — IOL subluxation or dislocation occurs with increasing frequency, as reported in several sessions of the European Society of Cataract and Refractive Surgeons meeting. The best way to deal with this complication may be to rescue the IOL rather than explant it, according to one surgeon.“I wouldn’t call it an epidemic, but for sure it is something we see more and more often. One of the reasons might be that we do more complicated cases. We dare more and implant IOLs in an increasing number of increasingly old people,” Ehud Assia, MD, said.
Study Dispels Claim That Childhood Vaccinations Cause Retinal Bleeding
A recent vaccination is often used as a defense in child abuse cases, particularly when evidence of retinal hemorrhage is presented. However, a new study shows no temporal link between vaccinations and retinal hemorrhage. Reuters Health Information
Uncategorized
Aerie, Ramot enter research collaboration
Aerie Pharmaceuticals and Ramot at Tel Aviv University have entered a research collaboration and license agreement for a preclinical anti-beta amyloid small molecule product candidate, according to a press release from Aerie.The product will be evaluat…
Uncategorized
Curly Nanowires Catch More Light to Power Nanoscale Electronic Circuits
WASHINGTON–(BUSINESS WIRE)–A nanospring shape induces more power output both in the broad spectrum range and at some desired single point.
Samenvatting: Novaliq GmbH versterkt uitvoerend bestuur Oliver Schlüter en Hartmut Voss
HEIDELBERG, Germany–(BUSINESS WIRE)–Novaliq GmbH, een farmaceutisch bedrijf dat moeilijk oplosbare medicijnen omvormt tot effectieve oogheelkundige therapieën, heeft vandaag bekendgemaakt dat Oliver Schlüter het bedrijf versterkt als algemeen directeur en financieel bestuurder. Daarnaast benoemt Novaliq Hartmut Boss tot hoofd bedrijfszaken. Dr. Schlüter was eerder financieel directeur van CureVac, waar hij een groot aandeel had in de transformatie een zeventig werknemers tellend onderzoeksbed